MedTrace Logo

Chart Review of the Efficacy of the GenesisPlus 1064 nm Nd:YAG Laser in the Treatment of Onychomycosis

NCT02445495 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2015-05-15

No results posted yet for this study

Summary

The purpose of this study is to determine if toenail onychomycosis can be reduced by means of exposure to laser energy from the Cutera® GenesisPlus 1064 Nd:YAG laser system.

Conditions

  • Onychomycosis

Interventions

DEVICE

GenesisPlus 1064 nm Nd:YAG laser

Genesis Plus 1064 nm Nd: YAG laser to treat onychomycosis

Sponsors & Collaborators

  • Cutera Inc.

    collaborator INDUSTRY

  • Jason K Rivers, MD, FRCPC, FAAD

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-11-30
Completion
2014-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02445495 on ClinicalTrials.gov